Predicting biologic therapy success in ulcerative colitis with ultrasound
Part of Digestive system clinical trials.
This study looks at how ultrasound imaging of the intestine and fat can help predict if biologic therapy will work for people with ulcerative colitis. It aims to find early signs that show which patients respond best to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have active ulcerative colitis (with symptoms like rectal bleeding, frequent stools, or mucus)
- You are not pregnant
- You have not had your colon removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses intestinal ultrasound to see if vedolizumab can heal the gut in people recently diagnosed with Crohn's disease. It aims to find early signs that the treatment is working.
This study looks at whether early stool tests (fecal immunochemical test and calprotectin) can predict when ulcerative colitis symptoms might return. It is for people who have never taken biologic medications.
This study compares how well intestinal ultrasound and colonoscopy measure disease activity in people with ulcerative colitis. The goal is to see if ultrasound can be a less invasive way to track inflammation.
This study looks at whether a simple stool test can tell if treatment is healing the gut lining in people with moderate to severe ulcerative colitis who are starting their first biologic medicine. If it works, this test might help doctors adjust treatment earlier.
This study compares two first-line biologic drugs for moderate to severe ulcerative colitis to see which works better and why. The goal is to help find the best biologic treatment for each patient.
This study looks at stool samples to see if certain markers can quickly tell whether a biologic medicine is starting to work for moderate-to-severe ulcerative colitis. If successful, this could help doctors make faster, smarter treatment decisions.
Hear when a new Predicting Biologics Success Via VAT Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.